Login
Toggle navigation
Videos
Categories
Trending
Paul Grint Discusses AmpliPhi Biosciences - Paul Grint, CEO, AmpliPhi Biosciences Corp
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Paul Grint Discusses AmpliPhi Biosciences
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Bogdan Badea of Hidroelectrica Shares Insights on the CHE Bretea Hydropower Project | Bogdan Badea ,CEO , Hidroelectrica SA.
00:10:00
YellowCake: Providing Pure Exposure to Uranium Prices
00:00:00
Explains why getting the COVID-19 vaccine is more important than ever - John (Jack) C. O'Horo, M.D. , Mayo Clinic
00:10:00
Introduction to Sano Galt: Junior Gold Exploration in Guinea
00:10:00
Steve Beard on Adtalem's Q4 Earnings, Labor Challenges, and Election Impact | Steve Beard , CEO, Adtalem Global Education.
00:10:00
Steven Dean Chairman and CEO of Artemis Gold was interviewed on BNN | Steven Dean, Chairman, Chief Executive Officer & Director, Artemis Gold Inc. (IE)
00:10:00
Advancing AI for Good: Microsoft and Waterloo AI Institute Unite for Innovation
00:10:00
"An Inevitable, Intensified Response to the Climate Crisis: Charting a Sustainable Path with Jennifer Anderson"
00:00:00
Anders Hultman, CEO, AroCell AB (publ)
00:10:00
TJ Rodgers: Capitalism, Environmentalism, and Corporate Responsibility|T. J. Rodgers
00:10:00
Challenges and Optimism: Assessing Brazil's Sanitation Future Through Expert Insights | Benedito Braga, CEO, Companhia de Saneamento Basico do Estado de Sao Paulo SABESP.
00:10:00
Latin Metals Inc: Strategic Growth Through Prospect Generator Model with Major Partners